Grundinformationen
- Standard-SMILES
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1- InChIKey
JRWZLRBJNMZMFE-UHFFFAOYSA-N- Summenformel
- C18H23NO3
- Durchschnittliche Molmasse
- 301,4 g/mol
- Monoisotopische Masse
- 301,1677936
Namen und Bezeichner
- Bevorzugter Name
- Dobutamine
- IUPAC
- 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol
- Englischer Name
- Dobutamine
- Summenformel
- C18H23NO3
- Molmasse
- 301.38
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
34368-04-2- PubChem CID
- 36811
- DTXSID
DTXSID3022958- ChEMBL
CHEMBL926- ChEBI
CHEBI:4670- UNII
- 3S12J47372
- EC Number
- 112-679-1
- Nikkaji
- J29.869G、J399.069I
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 3,4
- Polarare Oberfläche (TPSA)
- 72,7 Ų
- H-Brücken-Donoren
- 4
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 7
- Schwere Atome
- 22
- Formalladung
- 0
- Komplexität
- 305
Physikochemische Eigenschaften
- Siedepunkt
- 527.7 · 527.7±50.0 °C(Predicted)
- Dichte
- 1.189 · 1.189±0.06 g/cm3(Predicted)
- storage temp.
- 2 · 2-8°C
- pka
- 9.65 · 9.65±0.10(Predicted)
Sicherheit und Regulatorisches
Sicherheitsdaten
- wgk
- 3
- risk_code
- 20/21/22-63
- hazard_code
- Xn
- safety_code
- 22-26-36/37/39
Chemie und Industrie
Anwendungen
VerwendenDobutamine is predominantly a β1-agonist, with some activity at β2- receptors. Its primary effect is an increase in cardiac output as a consequence of increased contractility and HR and decreased afterload. Systolic arterial pressure may therefore increase, but peripheral resistance is reduced or unchanged. It is primarily used as an inotrope (inodilator) in low CO states. D obutamine increases SA node automaticity and conduction velocity in the atria, ventricles and AV node, with tachyarrhythmias occurring at higher doses. Dobutamine is administered as an i.v. infusion at a dose range of 0.5– 40 μg kg–1 min–1.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Anbieter30 Anbieter
Ergänzende Hinweise
DefinitionChEBI: A catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulan action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…